Inhibition of mesothelin as a novel strategy for targeting cancer cells.
about
Clinical impacts of mesothelin expression in gastrointestinal carcinomasMesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cellsSerum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice.Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenograftsIncorporation of porcine adenovirus 4 fiber protein enhances infectivity of adenovirus vector on dendritic cells: implications for immune-mediated cancer therapy.Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing.Unique cellular interactions between pancreatic cancer cells and the omentumMesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.Ovarian cancer stroma: pathophysiology and the roles in cancer development.Mesothelin expression and survival outcomes in triple receptor negative breast cancer.MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.Overexpression of sulfatase-1 in murine hepatocarcinoma Hca-F cell line downregulates mesothelin and leads to reduction in lymphatic metastasis, both in vitro and in vivoC-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.Mesothelin promotes invasion and metastasis in breast cancer cells.RalA is overactivated in medulloblastoma.Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis.Malignant mesothelioma: development to therapyPeritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment.Trial watch: Chemotherapy with immunogenic cell death inducers.The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
P2860
Q26748680-E96117D3-E8F0-4327-B066-BB35D00CA43DQ29048401-075C17C6-E2D7-4601-9A9F-EEDECEE89B38Q33929696-C69F16C3-8F4B-42A7-9AFD-8F2F033A78BFQ34278435-931A479C-428A-481E-832A-7E34740FF259Q34984956-21A34867-1DF4-4DCC-84CC-7C6A6D95CF5CQ35620238-B2A15C95-372A-47F7-9BE2-8FB0B32E00B9Q36261542-5653B79D-50CC-4CAA-AD48-8B0AF50DE15AQ36410426-8C580D84-C58D-4003-86AC-2D8AC451B9D6Q36864971-5B0883FE-8EA3-4E1F-99CD-CD52AF466A3FQ37017056-98424F86-1F1E-483B-8A93-9A6A49436B19Q37339008-E9B0C365-0BA5-4CC0-BA6D-D9DE75883BF8Q37499806-83DBEF6C-259C-46B1-B78F-F4692326707AQ37688894-0DD6EF38-6C44-40BE-BECB-3C86CF895C54Q39178281-35E7ECB8-ECAE-4917-8876-0E029D78F596Q39210075-7160D3C6-6517-4033-8F32-C69BD71D55FBQ39449209-D580271B-C7A4-4603-81E6-FD090A023980Q41234207-98CD81AA-8DEC-4902-BEBE-C19D9D6617A4Q41967712-74D10BEE-8B00-4F50-8846-4FA0C68AE09FQ47309343-44BE3470-E511-4F9A-A8AD-33344CCBE518Q55658029-0713B976-D2C0-4349-A117-3FC7C03B2FEEQ58726271-1FE4B590-9DB8-4635-8F07-57D92651CD99
P2860
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@ast
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@en
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@nl
type
label
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@ast
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@en
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@nl
prefLabel
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@ast
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@en
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@nl
P2093
P2860
P1433
P1476
Inhibition of mesothelin as a novel strategy for targeting cancer cells.
@en
P2093
Anna Meyer
Arkadiusz Z Dudek
Emma Borrego-Diaz
Faris Farassati
Farnaz Yamoutpoor
Mojtaba S Olyaee
Richard A Woo
Tuba Esfandyari
Vidya Bodempudi
P2860
P304
P356
10.1371/JOURNAL.PONE.0033214
P407
P577
2012-04-02T00:00:00Z